RT-PCR
BD Gains FDA Clearance for Combination COVID-19, Flu, RSV Molecular Test
The RT-PCR-based BD Respiratory Viral Panel for BD Max received a CE mark in 2022 and FDA Emergency Use Authorization earlier this year.
Diatech, Janssen Partner to Develop Molecular Diagnostics for Bladder Cancer
The bladder cancer test in development will profile genetic alterations in bladder cancer in three hours using real-time PCR.
Hologic Nabs FDA 510(k) Clearance for Respiratory Assay
The multiplex real-time RT-PCR test for SARS-CoV-2, influenza A and B, and RSV is designed for use on the firm's high-throughput Panther Fusion instrument.
SD Biosensor Eyes Global Expansion as Evaluations Find Rapid MDx System on Par With Competition
Premium
The sample-to-answer system can multiplex up to 12 targets and can run both isothermal assays and RT-PCR with results in 30 minutes or 60 minutes, respectively.
BGI Genomics Gets Australian Regulatory Approval for Multiplexed SARS-CoV-2, Influenza Test
The RT-PCR-based test is designed to simultaneously detect and differentiate SARS-CoV-2, influenza A, and influenza B from throat swab samples.